Neogenomics (NEO) Cash from Investing Activities Growth (1y) (2011 - 2026)
Neogenomics (NEO) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 465.38% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -1,600.38% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -2.89% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -13.29% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 32.46% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 35.74% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -91.12% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -480.95% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -353.86% |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | -240.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -240.45% |
| Dec 31, 2025 | -15.33% |
| Sep 30, 2025 | 92.12% |
| Jun 30, 2025 | -227.36% |
| Mar 31, 2025 | -75.49% |
| Dec 31, 2024 | -131.79% |
| Sep 30, 2024 | -116.89% |
| Jun 30, 2024 | -51.08% |
| Mar 31, 2024 | -38.82% |
| Dec 31, 2023 | 1,717.59% |
| Sep 30, 2023 | 595.97% |
| Jun 30, 2023 | 338.27% |
| Mar 31, 2023 | 97.00% |
| Dec 31, 2022 | 88.91% |
| Sep 30, 2022 | 71.41% |
| Jun 30, 2022 | 98.62% |
| Mar 31, 2022 | 107.79% |
| Dec 31, 2021 | 66.79% |
| Sep 30, 2021 | 79.23% |
| Jun 30, 2021 | -2,396.34% |